These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9100841)

  • 1. Mutagenic activity and specificity of hydrogen peroxide in the ad-3 forward-mutation test in two-component heterokaryons of Neurospora crassa.
    Han JS
    Mutat Res; 1997 Mar; 374(2):169-84. PubMed ID: 9100841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative differences in the spectra of genetic damage in 2-aminopurine-induced ad-3 mutants between nucleotide excision-repair-proficient and -deficient strains of Neurospora crassa.
    de Serres FJ; Brockman HE
    Mutat Res; 1991 Nov; 251(1):41-58. PubMed ID: 1834936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the spectra of genetic damage in formaldehyde-induced ad-3 mutations between DNA repair-proficient and -deficient heterokaryons of Neurospora crassa.
    de Serres FJ; Brockman HE
    Mutat Res; 1999 Sep; 437(2):151-63. PubMed ID: 10556619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the spectra of genetic damage in N4-hydroxycytidine-induced ad-3 mutations between nucleotide excision repair-proficient and -deficient heterokaryons of Neurospora crassa.
    de Serres FJ; Brockman HE
    Mutat Res; 1993 Feb; 285(2):145-63. PubMed ID: 7678887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the uvs-2 allele of Neurospora crassa on the mutagenic potency of two N-hydroxylaminopurines and 2-aminopurine in the ad-3 forward-mutation test.
    Brockman HE; de Serres FJ; Hung CY; Ong T
    Mutat Res; 1989 Jul; 218(1):1-11. PubMed ID: 2526296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of the specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora for risk assessment of environmental chemicals.
    de Serres FJ
    Mutat Res; 1991; 250(1-2):251-74. PubMed ID: 1834935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the mutagenicity and mutagen specificity of ethylenimine with triethylenemelamine in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV; Ong TM
    Mutat Res; 1995 May; 328(2):193-205. PubMed ID: 7739603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic potency and specificity of procarbazine in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
    Brockman HE; de Serres FJ
    Mutat Res; 1991 Jan; 246(1):193-204. PubMed ID: 1824718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of neocarzinostatin in Neurospora crassa.
    DeGraff WG
    Mutat Res; 1984 Sep; 128(2):127-35. PubMed ID: 6236365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethylene oxide: induction of specific-locus mutations in the ad-3 region of heterokaryon 12 of Neurospora crassa and implications for genetic risk assessment of human exposure in the workplace.
    de Serres FJ; Brockman HE
    Mutat Res; 1995 Apr; 328(1):31-47. PubMed ID: 7898502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Amino-N6-hydroxyadenine induces gene/point mutations and multiple-locus mutations, but not multilocus deletion mutations, in the ad-3 region of a two-component heterokaryon of Neurospora crassa.
    de Serres FJ; Brockman HE; Overton LK
    Mutat Res; 1991 Aug; 253(1):21-32. PubMed ID: 1831243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the homokaryotic state of the uvs-2 allele in Neurospora crassa on formaldehyde-induced killing and ad-3 mutation.
    de Serres FJ; Brockman HE; Hung CY
    Mutat Res; 1988 May; 199(1):235-42. PubMed ID: 2966296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forward-mutation tests on the antitumor agent ICR-170 in Neurospora crassa demonstrate that it induces gene/point mutations in the ad-3 region and an exceptionally high frequency of multiple-locus ad-3 mutations with closely linked sites of recessive lethal damage.
    de Serres FJ; Malling HV
    Mutat Res; 1994 Oct; 310(1):15-36. PubMed ID: 7523879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cytotoxic and mutagenic effects of selected mutagens on excision repair-sufficient and -deficient AD-3 mutants of Neurospora crassa.
    Ong T; Converse JO
    Mutat Res; 1983 Oct; 124(1):61-7. PubMed ID: 6226873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet-inactivation of conidia from heterokaryons of Neurospora crassa containing uv-sensitive mutations.
    Shelby MD; De Serres FJ; Stine GJ
    Mutat Res; 1975 Jan; 27(1):45-58. PubMed ID: 123634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the homokaryotic or heterokaryotic state of the uvs-2 allele in Neurospora crassa on mitomycin C-induced killing and ad-3 mutation.
    Brockman HE; de Serres FJ; Hung CY
    Mutat Res; 1985; 150(1-2):193-202. PubMed ID: 3158811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative comparison of spontaneous and chemical-induced specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV; Brockman HE; Ong TM
    Mutat Res; 1997 Apr; 375(1):53-72. PubMed ID: 9129679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two N-hydroxylaminopurines are highly mutagenic in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
    Brockman HE; de Serres FJ; Ong TM; Hung CY
    Mutat Res; 1987 Mar; 177(1):61-75. PubMed ID: 2950320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triethylenemelamine: induction of specific-locus mutations in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV
    Mutat Res; 1995 Mar; 327(1-2):87-111. PubMed ID: 7870102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. VII. Genetic lesions resulting in gene/point mutations at the ad-3B locus have different dose-response relationships.
    de Serres FJ
    Mutat Res; 1990 Oct; 232(2):115-40. PubMed ID: 2145510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.